ImCheck Therapeutics
Signal active
Organization
Contact Information
Overview
ImCheck Therapeutics is a developer of immuno-modulatory antibodies designed for the treatment of cancer and other immune-related diseases. The company's services are engaged in the discovery and development of immunomodulators for treating breast cancer, gastric, ovarian cancer cells and other solid solid tumours.
About
Industries
Biotechnology, Life Science, Health Care, Biopharma, Therapeutics
Founded
2015
Employees
11-50
Headquarters locations
Europe
Social
N/A
Profile Resume
ImCheck Therapeutics headquartered in Europe, operates in the Biotechnology, Life Science, Health Care, Biopharma, Therapeutics sector. The company focuses on Biotechnology and has secured $22.3B in funding across 120 round(s). With a team of 11-50 employees, ImCheck Therapeutics is actively contributing to advancements in Biotechnology. Their latest funding round, Series A - ImCheck Therapeutics, raised $21.9M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
7
Investors
5
Lead Investors
0
Total Funding Amount
$185.5M
Details
4
ImCheck Therapeutics has raised a total of $185.5M in funding over 4 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2019 | Early Stage Venture | 53.2M | ||
| 2020 | Early Stage Venture | 7.1M | ||
| 2022 | Late Stage Venture | 100.0M | ||
| 2017 | Early Stage Venture | 21.9M |
Investors
ImCheck Therapeutics is funded by 64 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| ImCheck Therapeutics | - | FUNDING ROUND - ImCheck Therapeutics | 21.9M |
| Kurma Partners | - | FUNDING ROUND - Kurma Partners | 21.9M |
| ImCheck Therapeutics | - | FUNDING ROUND - ImCheck Therapeutics | 21.9M |
| EQT Life Sciences | - | FUNDING ROUND - EQT Life Sciences | 21.9M |
Recent Activity
There is no recent news or activity for this profile.